To show the potential of the Cell Marker Accordion in identifying disease-critical cell types, we analyzed a published scRNA-seq dataset of CD34+ bone marrow cells from 5 healthy controls and 14 AML patients59. Here, CD34 is linked to acute myeloid leukemia.